Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.
about
Antipsychotics in the treatment of autismRisperidone for autism spectrum disorderRisperidone for autism spectrum disorderEfficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic childrenOff-label indications for atypical antipsychotics: A systematic reviewMonoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effectsAutism spectrum disorders: early detection, intervention, education, and psychopharmacological managementPharmacotherapy to control behavioral symptoms in children with autismAutism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.Medication treatment in subjects with autistic spectrum disorders.Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.A systematic review of the use of atypical antipsychotics in autism.Typical neuroleptics in child and adolescent psychiatry.Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review.Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.Pediatric psychopharmacotherapy: a review of recent research.Outcome measures for clinical drug trials in autism.Drug-induced movement disorders in children and adolescents.Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.Autism: review of neurochemical investigation.Treatment of inattention, overactivity, and impulsiveness in autism spectrum disordersTreatment of Autism Spectrum Disorder in Children and Adolescents.Control of psychomotor agitation and aggressive behavior in patients with autistic disorder: a retrospective chart review.The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.Diagnostic and assessment issues related to pharmacotherapy for children and adolescents with autism.Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?Managing irritability and aggression in autism spectrum disorders in children and adolescents.Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.Autism spectrum disorders: an overview on diagnosis and treatment.Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder.Antipsychotics use in children and adolescents: An on-going challenge in clinical practice.Revisiting loxapine: a systematic review.Drugs, learning and cognitive function in children--an update.Fenfluramine treatment of autism.Risperidone monotherapy in preschool children with pervasive developmental disorders.Fenfluramine treatment of twenty children with autism.Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disordersPaliperidone palmitate in a child with autistic disorder.Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: case report.Further speculations on possible dopamine-opioid link in autism.
P2860
Q22241891-5A458EF9-0A78-46A1-83B4-0944ED7F74BFQ24246315-91798817-BA18-4060-B2D3-1BC07C0BC9EFQ24246471-1BE547BD-D7A6-4FE2-A65A-68BD72E8B71BQ24564288-36FA0AD6-9177-49EA-BE28-22BFC88727F9Q24803302-889A1C19-0F44-40EB-8DEB-52B39A76C4E2Q28188009-6F98D8ED-84B8-469F-9B9C-8EC8C8122638Q28212094-33A56058-91F5-4D59-B2F6-87FB35A3955CQ28265801-B7616904-ABCF-481A-902C-8846FECA9FBDQ30607088-B160A2A0-CBCC-4D7F-8397-A9ADB92A4DA3Q30623213-EA85F57F-DEFF-4269-91C1-A6A02E744F5EQ33891726-09CC7B3B-5428-43D1-B4E1-7CD1C54FAF4EQ33958570-9664741A-B5FE-4D9C-864A-EEB949F01622Q34120052-E3241289-8CD6-48BF-8587-BA0A9975E46FQ34407949-4B67E4DF-2B30-456E-819F-E2A057DBABCCQ34597411-1870BA3E-2DCC-4750-AF34-6323A4751984Q35309965-4E01B5B6-BF22-4CE1-8B94-5F22976E1682Q35636181-1483CA6B-DBAC-4166-A359-E04A525DAF6CQ36040766-D2D7B678-A198-46BE-8949-78A2BCBD2402Q36443014-0A1CE3C9-7FCA-44DC-BD66-F47A9D9A8F26Q36605375-4551C30F-6715-481D-8864-72946A6D36BEQ37248753-EBC1EB79-8827-4D75-B8A4-A0274D80092EQ37299857-669D9714-11EF-43CE-9086-6FDE28A92126Q37307611-3BADA307-7401-43EB-9CB2-8F6A5DCFA744Q37445011-3D2BEBC6-EB1D-4DB1-ADE7-1C0BB1E1705BQ37523280-F763BC3E-EF01-42E3-B85B-5CBCB8A49B02Q37685257-7057CB11-CC02-42A9-AB7F-616539ACD722Q37803576-557F228E-2232-4FFB-85ED-0969983D0500Q38095762-16D8F931-3942-4926-B170-049E00B1E683Q38154183-FD9A1132-FEDE-445D-871C-F21E4865EAF9Q38164696-618E7825-3FEC-4779-9451-8339332780B9Q38217992-E11417C7-9051-4537-84A5-219447A85ED4Q38413932-7DE2A0D3-0EDA-4A71-95F5-EDA64A90C669Q39467904-A498B9D6-14FB-44C6-B85A-CE01E403364AQ39634035-814EB600-ABAF-4387-8697-303496EF6764Q40601138-0FBADD72-9CCC-450F-B296-7B8883D1F415Q42193115-7F0545A7-E136-4E85-A967-D70E142D6F28Q42809107-940C3087-05F2-46C5-A737-EFAB27FFFA6AQ43025940-BA868D75-BE6B-4E57-BC78-78BBCF02E43CQ43164580-634EC35E-191C-49B7-9574-53537FB5633AQ44350777-F8924556-F0F8-4E77-B56C-2E32CA3C78FC
P2860
Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@en
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@nl
type
label
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@en
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@nl
prefLabel
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@en
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@nl
P2093
P356
P1476
Haloperidol in the treatment o ...... rning and behavioral symptoms.
@en
P2093
P304
P356
10.1176/AJP.141.10.1195
P407
P577
1984-10-01T00:00:00Z